Trauma Therapy Composition Stabilizing Cardiac Electrical Conductivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current resuscitation therapies for trauma victims, particularly those experiencing severe hemorrhagic shock or cardiac events, lack effective methods to stabilize the heart and prevent cardiac destabilization, leading to high mortality rates due to inadequate tissue protection and inflammatory responses.
Innovation Solution
A method involving the administration of a composition containing potassium channel openers or agonists, adenosine receptor agonists, and local anesthetics, which can help stabilize the heart and reduce tissue injury by modulating membrane excitability, attenuating inflammatory responses, and reducing ion imbalances, thereby protecting key organs such as the heart and brain.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current resuscitation therapies are used for trauma victims, then basic life support can be provided, but cardiac destabilization occurs and mortality rates remain high
Solution Approach 1:
The patent applies preliminary action by administering the composition before traumatic injury occurs. The composition is given prophylactically to trauma victims immediately after injury to prevent cardiac destabilization and tissue injury before they can develop. This preemptive approach addresses the contradiction by establishing protective effects in advance, improving survival rates while preventing cardiac destabilization rather than treating it after occurrence.
2Quantity of substance
If volume expanders are administered to maintain blood volume, then hemorrhagic shock can be managed, but tissue oxygenation remains compromised
Solution Approach 1:
The patent applies parameter changes by modifying the chemical and electrical parameters of cell membranes through the composition's active ingredients. The potassium channel openers, adenosine receptor agonists, and local anesthetics alter membrane potential, ion channel activity, and cellular electrical properties. These parameter changes improve tissue oxygenation and prevent ischemic injury independently of blood volume expansion, addressing the contradiction by changing cellular-level parameters rather than relying solely on volume replacement.
3Ease of operation
If trauma patients receive conventional treatment, then immediate life support can be provided, but inflammatory responses lead to multiple organ failure
Solution Approach 1:
The patent applies the blessing in disguise principle by converting the harmful inflammatory response into a beneficial protective effect. The composition modulates the inflammatory cascade through adenosine receptor agonism and potassium channel activation, transforming the potentially damaging inflammatory cascade into a controlled, protective response. This resolves the contradiction by converting the harmful inflammatory reaction into a beneficial protective mechanism that prevents multiple organ failure while maintaining ease of administration.
4Device complexity
If no specific cardiac protection is provided, then treatment simplicity is maintained, but electrical instability of heart muscle occurs
Solution Approach 1:
The patent applies merging by combining multiple protective mechanisms into a single composition administered through one protocol. The formulation integrates potassium channel openers, adenosine receptor agonists, and local anesthetics into one unified treatment that simultaneously addresses electrical instability, ischemic injury, and inflammatory responses. This resolves the contradiction by merging multiple therapeutic functions into a single administration, maintaining treatment simplicity while providing comprehensive cardiac protection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed solution effectively reduces injury to cells and tissues by stabilizing the heart, preventing cardiac arrest, and minimizing inflammatory responses, thereby improving survival rates and clinical outcomes in trauma patients.
Implementation Method 1
a potassium channel opener or agonist
Implementation Method 2
an adenosine receptor agonist
Implementation Method 3
a local anaesthetic
Data Source
AI summary
The invention provides a method of reducing injury to cells, tissues or organs of a body following trauma by administering a composition to the body following trauma, including: (i) a potassium channel opener or agonist and/or an adenosine receptor agonist and (ii) a local anaesthetic. Also provided is a composition for reducing injury to cells, tissues or organs of a body following trauma including: (i) and (ii). The composition may be hypertonic.